Provider
QP67-24 Commercial Pharmacy Benefit Exclusion for edaravone, Kisunla™, PiaSky®, and Tecelra®
Program effective Date: Aug 28, 2024
Documents & Forms Results
Displaying 441 - 450 of 3630 results
Provider
QP65-24 PCA Agency Requirements
Program effective Date: Aug 28, 2024
Provider
QP66-24 Reminder: Patient Complaint Policy and Process Requirements
Program effective Date: Aug 28, 2024
Provider
QP62-24 Commercial Pharmacy Benefit Update: New and Revised Drug-Related Prior Authorization (PA) Requirement Notification, Effective October 1, 2024
Program effective Date: Aug 14, 2024
Provider
QP64-24 MHCP Pharmacy Benefit Exclusion for Rytelo™
Program effective Date: Aug 14, 2024
Provider
QP63-24 MHCP Pharmacy Benefit Update: Revised Drug-Related Prior Authorization (PA) Requirement Notification, Effective September 1, 2024
Program effective Date: Aug 14, 2024
Provider
P49-24 eviCore Healthcare Specialty Utilization Management (UM) Program: Radiation Oncology Clinical Guideline Updates
Program effective Date: Aug 01, 2024
Provider
P50-24 New Medical, Medical Drug and Behavioral Health Policy Management Updates, Effective October 7, 2024
Program effective Date: Aug 01, 2024
Provider
P52-24 Medical Policy Updates: Coupe Health and Self-Funded Benefit Plans Managed by Blue Cross and Blue Shield of Alabama
Program effective Date: Aug 01, 2024
Provider
P53-24 MagellanRx Management, a Prime Therapeutics Company (UM) Program: Medical Drug Updates
Program effective Date: Aug 01, 2024